Financing, Equity Capital Markets

Avadel Pharmaceuticals

04/20
|
$125.0 Million
Piper Sandler served as bookrunner for Avadel Pharmaceuticals PLC on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma